No regulatory approvals required for cell therapy use.
Many uses besides diabetes. A platform technology.
Day surgery only to install graft under a local anaesthetic.
A very strong hint that PNV will be involved in future funding and possible acquisition.
I think we will hear more about that sooner that later.
A lot to like about that presentation.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
-0.003(0.21%) |
Mkt cap ! $823.8M | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.21 | $1.17 | $1.151M | 965.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 216 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 37861 | 28 |
View Market Depth
| Last trade - 14.43pm 07/08/2025 (20 minute delay) ? |
| PNV (ASX) Chart |